What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea?

Introduction 75Selenium taurocholic acid (SeHCAT) scanning diagnoses bile acid malabsorption/bile acid diarrhoea (BAM/BAD) and defines optimal treatment. Approximately 2% of the population have BAM/BAD.AimTo evaluate the cost of delayed diagnosis of BAM/BAD.MethodsPatients’ notes who underwent SeHCA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontline gastroenterology 2019-01, Vol.10 (1), p.72-76
Hauptverfasser: Fernandes, Darren C R, Poon, Dennis, White, Laura L, Andreyev, H Jervoise N
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction 75Selenium taurocholic acid (SeHCAT) scanning diagnoses bile acid malabsorption/bile acid diarrhoea (BAM/BAD) and defines optimal treatment. Approximately 2% of the population have BAM/BAD.AimTo evaluate the cost of delayed diagnosis of BAM/BAD.MethodsPatients’ notes who underwent SeHCAT scanning in three hospitals over a 1-year period were reviewed retrospectively. Scan results and treatment response were recorded. Package-of-care costs were calculated using costing tools from the National Institute for Health and Care Excellence and from United Lincolnshire Hospitals Trust business unit.ResultsBetween June 2016 and May 2017, 19 men and 37 women (median age 58 (range 19–83)) of 3860 new patients seen in gastroenterology clinics were referred for SeHCAT scanning. Sixty-four per cent of scans were abnormal: 13 demonstrated severe (
ISSN:2041-4137
2041-4145
DOI:10.1136/flgastro-2018-101011